Vasodilation and Blood Pressure-Lowering Effect of 3-Demethyl-2-Geranyl-4-Prenylbellidifoline, a Xanthone Obtained from Garcinia achachairu, in Hypertensive Rats
- PMID: 38498544
- PMCID: PMC10892760
- DOI: 10.3390/plants13040528
Vasodilation and Blood Pressure-Lowering Effect of 3-Demethyl-2-Geranyl-4-Prenylbellidifoline, a Xanthone Obtained from Garcinia achachairu, in Hypertensive Rats
Abstract
3-demethyl-2-geranyl-4-prenylbellidifoline (DGP), a natural xanthone isolated from Garcinia achachairu, has previously demonstrated remarkable diuretic and renal protective actions. The present study expands its actions on the cardiovascular system by evaluating its vasorelaxant and blood pressure-lowering effects in spontaneously hypertensive rats (SHRs). Aortic endothelium-intact (E+) preparations of SHRs pre-contracted by phenylephrine and exposed to cumulative concentrations of G. achachairu extract, fractions, and DGP exhibited a significant relaxation compared to vehicle-only exposed rings. The non-selective muscarinic receptor antagonist (atropine), the non-selective inhibitor of nitric oxide synthase (L-NAME), as well as the inhibitor of soluble guanylate cyclase (ODQ) altogether avoided DGP-induced relaxation. Tetraethylammonium (small conductance Ca2+-activated K+ channel blocker), 4-aminopyridine (a voltage-dependent K+ channel blocker), and barium chloride (an influx-rectifying K+ channel blocker) significantly reduced DGP capacity to induce relaxation without the interference of glibenclamide (an ATP-sensitive inward rectifier 6.1 and 6.2 K+ channel blocker). Additionally, administration of DGP, 1 mg/kg i.v., decreased the mean, systolic, and diastolic arterial pressures, and the heart rate of SHRs. The natural xanthone DGP showed promising potential as an endothelium-dependent vasorelaxant, operating through the nitric oxide pathway and potassium channels, ultimately significantly reducing blood pressure in hypertensive rats.
Keywords: bioactive; hypertension; spontaneously hypertensive rats; vasculature; xanthone.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
Vasorelaxant Action of the Chloroform Fraction of Orthosiphon stamineus via NO/cGMP Pathway, Potassium and Calcium Channels.Am J Chin Med. 2016;44(7):1413-1439. doi: 10.1142/S0192415X16500798. Epub 2016 Oct 27. Am J Chin Med. 2016. PMID: 27785939
-
Ethyl Acetate Fraction from Leandra dasytricha (A. Gray) Cong. Leaves Promotes Vasodilatation and Reduces Blood Pressure in Normotensive and Hypertensive Rats.Evid Based Complement Alternat Med. 2021 Nov 15;2021:7203934. doi: 10.1155/2021/7203934. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34819984 Free PMC article.
-
Vasorelaxant and antihypertensive effects of Tianshu Capsule on rats: An in vitro and in vivo approach.Biomed Pharmacother. 2019 Mar;111:188-197. doi: 10.1016/j.biopha.2018.12.061. Epub 2018 Dec 21. Biomed Pharmacother. 2019. PMID: 30583226
-
Role of K+ and Ca2+ Channels in the Vasodilator Effects of Plectranthus barbatus (Brazilian Boldo) in Hypertensive Rats.Cardiovasc Ther. 2023 Nov 17;2023:9948707. doi: 10.1155/2023/9948707. eCollection 2023. Cardiovasc Ther. 2023. PMID: 38024105 Free PMC article.
-
Mechanisms of the vasorelaxant effect of 1, 5-dihydroxy-2, 3-dimethoxy-xanthone, an active metabolite of 1-hydroxy-2, 3, 5-trimethoxy-xanthone isolated from a Tibetan herb, Halenia elliptica, on rat coronary artery.Life Sci. 2008 Jan 2;82(1-2):91-8. doi: 10.1016/j.lfs.2007.10.014. Epub 2007 Nov 1. Life Sci. 2008. PMID: 18045622
Cited by
-
Edible Plant-Derived Xanthones as Functional Food Components for Metabolic Syndrome Mitigation: Bioactivities and Mechanisms.Foods. 2025 Jul 1;14(13):2344. doi: 10.3390/foods14132344. Foods. 2025. PMID: 40647096 Free PMC article. Review.
References
-
- Précoma D.B., de Oliveira G.M.M., Simão A.F., Dutra O.P., Coelho O.R., Izar M.C.d.O., Póvoa R.M.D.S., Giuliano I.d.C.B., Filho A.C.d.A., Machado C.A., et al. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology—2019. Arq. Bras. Cardiol. 2019;113:787–891. doi: 10.5935/abc.20190204. - DOI - PMC - PubMed
-
- Gomes C.S., Gonçalves R.P.F., da Silva A.G., de Sá A.C.M.G.N., Alves F.T.A., Ribeiro A.L.P., Malta D.C. Factors Associated with Cardiovascular Disease in the Brazilian Adult Population: National Health Survey, 2019. Rev. Bras. Epidemiol. 2021;24:e210013. doi: 10.1590/1980-549720210013.supl.2. - DOI - PubMed
-
- Martin J.F.V., Toledo J.Y. 7a Diretriz Brasileira de Hipertensão Arterial—Sociedade Brasileira de Cardiologia/Departamento de Hipertensão Arterial. Rev. Bras. Hipertens. 2017;24:72–74.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous